NAMS
NewAmsterdam Pharma Company N.V. · Healthcare
CFO Mayur Ian Somaiya sold $3.3M of NewAmsterdam Pharma Company N.V.
Sold$3,260,618
$32.61Price
100,000Shares
−63%Stake
What NAMS did after the filing
- The stock from Thu, Jan 22 close, $34.81
- −14.2%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 6 close.
Traded Tue, Jan 20. Filed Thu, Jan 22, 12:24 PM ET, during the session. Returns use the Jan 22 close and the Mar 6 close. Not investment advice.